Filter
30
Featured
Language
Document type
Studies & Reports
14
Guidelines
6
Strategic & Response Plan
4
Resource Platforms
2
No document type
2
Manuals
1
Infographics
1
Countries / Regions
Global
4
Latin America and the Carribbean
3
Eastern Europe and Central Asia
2
Western and Central Europe
2
China
1
Africa
1
Western Pacific Region
1
Mali
1
Authors & Publishers
World Health Organization WHO
16
Africa CDC
2
Pan American Health Organisation PAHO
2
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
European Centre for Disease Prevention and Control ECDC
1
Food and Agriculture Organization of the United Nations FAO
1
Global Antimicrobial Resistance and Use Surveillance System (GLASS)
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
O’Neill, J.
1
Patricia M.C. Huijbers, Carl-Fredrik Flach, D.G. Joakim Larsson
1
Quadripartite: Food and Agriculture Organization of the United Nations FAO
1
Review on Antimicrobial Resistance
1
The Center for Disease Dynamics Economics & olicy CDDEP
1
UN Environment Programme UNEP
1
WHO Europe
1
World Health Organisation
1
World Health Organisation (WHO)
1
World Health Organization WHO, Regional Office of Europe
1
World Organisation for Animal Health WAHO
1
Publication Years
Category
Policies
2
Drugs & Medical Equipment
2
Studies & Reports
2
HIV & STI
1
Toolboxes
Surveillance
30
International
4
Antimicrobial Resistance (AMR)
3
Platforms and initiatives
2
Rational use of Medicine
2
Pharmacovigilance
2
Country specific
1
Stewardship
1
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med... more
2016-2018 Early implementation, This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (... more
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ... more
The animal health subsector within the agriculture sector is the gatekeeper of antimicrobial resistance (AMR) in livestock, aquaculture, animal products, and the immediate animal environment. In support of member countries taking responsibility for and moving forward with putting AMR monitoring and ... more
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas... more
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control.... more
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy... more
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig... more
9 June 2021 Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G... more
ResistanceMap is an interactive collection of charts and maps that summarize national and subnational data on antimicrobial use and resistance worldwide.
Surveillance of antimicrobial resistance in Europe 2020 data: executive summary
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance... more
Antimicrobial resistance (AMR) represents a major threat to human health with significant global economic and security implications. In 2015, WHO Member States unanimously approved a Global Action Plan to tackle AMR (GAP-AMR). The goal of GAP-AMR is “to ensure, for as long as possible, continuity ... more
En 2014, la soixante-septième Assemblée Mondiale de la Santé a exprimé sa préoccupation croissante au sujet de la situation de la RAM, et elle a exhorté les pays membres à renforcer leurs programmes d’action nationale ainsi que la collaboration internationale. Dans sa résolution WHA67.25... more
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ... more
Antimicrobial resistance (‎AMR)‎ is impacting our health, economies and development. Up to 5.2 million people may die because of resistant bacterial infections across the Western Pacific Region from 2020-2030. Childbirth, surgery, cancer treatment and other interventions will become impossibly d... more